Inktone Inc

Nanosmart Pharmaceuticals is a cutting-edge biotechnology company based in Mission Viejo, CA, dedicated to developing a human-derived anti-nuclear antibody ANA that specifically targets areas of necrosis found in various tumor types, with a particular focus on rare pediatric cancers. Driven by their mission to enhance the safety and effectiveness of existing pharmaceutical products, Nanosmart utilizes their tumor-targeting technology to create a diverse product pipeline, enabling them to collaborate with industry partners in the development of novel therapies for a wide range of diseases. With a strong foundation in intellectual property, orphan drug designations, and the formulation of targeted nanoparticle delivery platforms, Nanosmart Pharmaceuticals is making significant progress in revolutionizing cancer treatment and improving patient outcomes.Generated from the website